News Release

Intravenous Vitamin C for patients hospitalized with COVID-19

JAMA

Peer-Reviewed Publication

JAMA Network

About The Study: In hospitalized patients with COVID-19, vitamin C had low probability of improving the primary composite outcome of organ support–free days and hospital survival in two harmonized randomized clinical trials. 

Authors: Neill K. J. Adhikari, M.D.C.M., M.Sc., of the Sunnybrook Health Sciences Centre in Toronto, and Francois Lamontagne, M.D., M.Sc., of the Universite de Sherbrooke in Sherbrooke, Canada, are the corresponding authors.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2023.21407)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: This study is being released to coincide with presentation at the European Society of Intensive Care Medicine Lives 2023 36th Annual Congress.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.21407?guestAccessKey=0ae1da3d-e149-40f9-84fc-0645baaf9e4a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102523


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.